Our response to the COVID-19 pandemic
X-ray Products support initial COVID-19 assessment of severity and monitoring

Our response to the COVID-19 pandemic

X-ray imaging is a relevant diagnostic modality for patients with COVID-19 disease, especially if the availability of other diagnostic methods becomes limited due to a rapid increase of infected patients. In many locations isolated areas are set up for the diagnosis and therapy of COVID-19 disease to manage the increased number of patients. There are solutions available to integrate X-ray machines into these isolated environments.

 

Clinical considerations that support X-ray as a highly suitable solution

  • Chest X-ray (CRX) imaging is the most common exam in emergency departments, standing exams are the gold standard for chest X-rays1, 2 , and might be necessary for baselining
  • Medium and severe cases, i.e. pneumonia, can also be seen in 2D, triaging is important to keep CT available for severe cases
  • Stationary X-ray allows standing chest X-rays as well as lying chest examinations in a patient bed in extra allocated rooms
  • Staff can stay inside the X-ray room and does not have to move between control room (“clean” environment) and X-ray room ("infectious" environment)
  • Mobile X-ray systems are used to follow-up on particularly severe cases, since the device is driven to the patient in the intensive care unit, for example, and the patient does not have to be transported through the hospital effortfully

Clinical evidence

  • Viral testing (RT-PCR) is considered the first-line test to diagnose COVID-191. However, CXR or CT can be helpful in the initial assessment of severity and monitoring of disease progression, if clinically indicated for severe cases2.
  • Most patients with a higher disease severity show abnormal chest radiographs3.
  • Typical radiographic findings include airspace opacities, ground-glass opacities (GGO), and consolidations4.

 

X-ray Products as a response to the COVID-19 pandemic

Evaluation of pneumonia with radiography

Radiography supports initial assessment of severity and monitoring of disease progression. Chest radiographs can show characteristic signs of viral acquired pneumonia. MULTIX Impact5 is a flexible, modular radiography system which covers a wide range of clinical requirements. Siemens Healthineers offers specific solutions for deployment in temporary COVID-19 diagnostic and therapeutic setups. These systems can also be installed in in stationary indoor and outdoor container solutions to provide access in high-demand or isolated areas.

MULTIX Impact

Monitoring and triaging of pneumonia with mobile radiography

Mobile radiography systems help with the monitoring of disease progression in particularly severe cases. The devices can be driven directly to patients in the intensive care unit, for example, eliminating the need for patients to be transported through the hospital. MOBILETT Elara Max6 offers improved hygienic conditions thanks to antimicrobial coating, fully integrated cables, and smooth and closed surfaces.

MOBILETT Elara Max

Example of a clinical setup with an isolated area for COVID-19 cases

Our floor-mounted radiography machine MULTIX Impact can be installed in various environments set up specifically for COVID-19 disease treatment, not only in dedicated X-ray rooms but also in open building or outdoor environment by indoor room and outdoor container solutions.

Fully digital education

Online and remote training help staff to quickly get to grips with new systems and start operating them with confidence.

 

 

Preventing contaminated medical devices in the context of COVID-19

Patients infected with COVID-19 which undergo exams in medical devices might transmit the disease via contamination of the systems surfaces. Disinfecting the systems after each patient is recommended.

Read our recommendations how to prevent contaminated medical devices.

Disinfecting X-ray Products

Prodotti correlati, Servizi & Risorse

1ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection

2German Radiological Society: https://www.drg.de/de-DE/5995/covid-19/

3Arentz et al. JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4326

4Hosseiny et al. AJR 2020; 214:1-5

5MULTIX Impact is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.

6MOBILETT Elara Max is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.